Influenza

Plant-Based Vaccine Manufacturing for Influenza, Implications for Future Vaccines

By

Tori Rodriguez, MA, LPC, AHC

An emerging body of research highlights plant-based vaccine manufacturing as a potential solution to risks posed by traditional egg-based manufacturing.

How to Prepare Patients for the New Influenza Season During COVID-19 Pandemic

By

Jessica Kovalchick, RPA-C

The Advisory Committee on Immunization Practices encourages all Americans to receive the flu vaccine between September and October.

Overcoming Challenges to Create a Universal Influenza Vaccine

By

Jasenka Piljac Žegarac, PhD

Researchers from the National Institute of Allergy and Infectious Diseases are working to develop a universal influenza vaccine.

Register-Based Cohort Studies Optimal for Estimates of Influenza Vaccine Effectiveness

By

Maria Arini Lopez, PT, DPT, CSCS, CMTPT

Researchers evaluated 3 different study designs to determine their accuracy in measuring influenza vaccine effectiveness among older patients.

Influenza A(H3N2) Predominant Strain During 2021 to 2022 Season

Throughout the 2021 to 2022 influenza season, the predominant virus was influenza A(H3N2), according to published research.

NIH Trial Underway for Universal Flu Vaccine

The National Institutes of Health Clinical Center has begun a phase I trial of a potential universal influenza vaccine.

Influenza Vaccination Decreases Risk of Mortality in Older Adults With Cardiovascular Disease

By

Maria Arini Lopez, PT, DPT, CSCS, CMTPT

Researchers assessed the protective effects of influenza vaccination among older adults with cardiovascular disease.

Does Influenza Vaccination Benefit Patients Hospitalized With Diabetes?

By

Pam Brick

Does influenza vaccination protect patients hospitalized for diabetes against the risk for poor outcomes and complications?

Exercise May Boost Immune Response to Flu Vaccine

Physical activity and acute exercise offer some benefit for influenza vaccination response, according to a review published online.

FDA Authorizes Direct-to-Consumer Test to Detect COVID-19, Influenza, and RSV

By

Brian Park, PharmD

The test is the first non-prescription multi-analyte COVID-19 test that allows individuals to test nasal swab samples self-collected at home.

Concomitant Flu Vaccine, COVID-19 Booster in Older Adults: Safety, Immunogenicity

By

Pam Brick

A phase 2 study assessed safety and immunogenicity of administering a high-dose quadrivalent influenza vaccine with a mRNA-1273 vaccine booster dose in older adults.